About Celares
Celares is a company based in Berlin (Germany) founded in 2003 by Ralf Kraehmer, Frank Leenders, and Guenther Paetz was acquired by Biosynth in July 2023. Celares operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Berlin, Germany
- Founders Ralf Kraehmer, Frank Leenders, Guenther Paetz
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Celares
Detailed funding history for Celares
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Celares
Celares has secured backing from 1 investor. Prominent investors backing the company include Biosynth.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biosynth is engaged in supplying critical raw materials and services for life sciences and diagnostics.
|
Locked | Locked | Locked |
Investor details for Celares
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Celares
Investment portfolio details for Celares
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Celares
Detailed financials for Celares
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Celares Comparisons
Peer comparison for Celares
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Celares
Celares operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of Celares
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Celares
Complete news archive for Celares
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Celares
Celares was founded in 2003.
Celares is headquartered in Berlin, Germany. It is registered at Berlin, Berlin, Germany.
Celares was founded in 2003 in Berlin, Germany, within the biopharmaceutical sector. PEGylation technologies are focused on for enhancing peptide and protein drugs through prolonged half-life, reduced immunogenicity, and improved stability. Patent applications are held for branched, monodispersed PEG reagents. Contract development services and customized reagent synthesis are also provided to support biopharmaceutical operations.
Celares's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Celares has 1 investor. Key investors include Biosynth.